JOURNAL ARTICLE

First U.S. over-the-counter birth control pill gets FDA approval and will be available early next year.

  • Published In: Fortune.com, 2023. P. N.PAG 1 of 3

  • Database: Business Source Ultimate 2 of 3

  • Authored By: Perrone, Matthew 3 of 3

Abstract

The article discusses the U.S. Food and Drug Administration's approval of the first over-the-counter birth control pill, Opill, developed by Perrigo, allowing American women and girls to purchase it without a prescription. This decision marks a significant change in contraceptive access, as hormone-based pills have traditionally required prescriptions since the 1960s. Advocates for women's health have supported this move, highlighting the barriers many face in obtaining prescriptions, particularly among teens, women of color, and those with low incomes. Opill, which contains only progestin, is expected to be available in stores and online by early next year, with no age restrictions on its sale. [Extracted from the article]

Additional Information

  • Source:Fortune.com. 2023/07, pN.PAG
  • Document Type:Article
  • Subject Area:History
  • Publication Date:2023
  • Accession Number:164939689
  • Copyright Statement:Copyright of Fortune.com is the property of Fortune Media (USA) Corporation and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.